Key facts
- This page summarizes Jonathan D. Root's Form 3 filing for Omada Health, Inc. (OMDA).
- 0 reported transactions and 10 derivative rows are listed below.
- Accepted by SEC: 05 Jun 2025, 16:44.
Key filing fact
Ownership activity is grounded in SEC Form 3 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
No transaction description listed
No transaction description listed
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
No transaction description listed
No transaction description listed
No transaction description listed
No transaction description listed
No transaction description listed
No transaction description listed
No transaction description listed
No transaction description listed
No transaction description listed
No transaction description listed
Additional SEC filing notes
Footnote F1
Reflects a 1-for-3 reverse stock split of the Issuer's outstanding common stock effected on May 27, 2025.
Footnote F2
Shares held by U.S. Venture Partners X, L.P.
Footnote F3
Shares held by USVP X Affiliates, L.P.
Footnote F4
Presidio Management Group X, L.L.C. ("PMG X"), the general partner of U.S. Venture Partners X, L.P. and USVP X Affiliates, L.P. (together, the "USVP X Funds"), has sole voting and dispositive power with respect to the shares held by the USVP X Funds. The Reporting Person is a managing member of PMG X, and may be deemed to share voting and dispositive power over the shares held by the USVP X Funds. The Reporting Person disclaims beneficial ownership of such shares, except to the extent of any pecuniary interest therein.
Footnote F5
Each share of Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series C-1 Preferred Stock and Series D Preferred Stock is convertible into approximately 0.33333 shares of the Issuer's common stock immediately prior to the closing of the Issuer's initial public offering after giving effect to the 1-for-3 reverse split of the Issuer's common stock effected on May 27, 2025. These shares are reported in Table II above on an as-converted basis and have no expiration date.
SEC remarks
Exhibit 24.1 - Power of Attorney